Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Allogene Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 155 | 2 | 170 | +17 |
| Shares | 130.3M | 156.8K | 122.2M | −7.90M (−6.1%) |
| Value | $413.3M | $497.6K | $392.4M | −$20.4M (−4.9%) |
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Allogene Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (22)
Institutions that held Allogene Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| EcoR1 Capital, LLC | 4,488,200 | $14.2M |
| Rhenman & Partners Asset Management AB | 300,000 | $951.0K |
| Simplify Asset Management Inc. | 245,000 | $776.6K |
| Marshall Wace, LLP | 228,642 | $724.8K |
| Schroder Investment Management Group | 168,864 | $535.3K |
| Susquehanna Fundamental Investments, LLC | 161,673 | $512.5K |
| Profund Advisors LLC | 130,639 | $414.1K |
| Squarepoint Ops LLC | 121,792 | $386.1K |
| Tudor Investment Corp Et Al | 73,998 | $234.6K |
| Keebeck Wealth Management, LLC | 46,000 | $145.8K |
| E Fund Management Co., Ltd. | 40,325 | $128.0K |
| Penserra Capital Management LLC | 28,284 | $89.0K |
| Martingale Asset Management L P | 27,526 | $87.3K |
| Bayesian Capital Management, LP | 26,500 | $84.0K |
| Franklin Resources Inc | 24,853 | $78.8K |
| Ci Investments Inc. | 14,936 | $47.0K |
| Corton Capital Inc. | 12,628 | $40.0K |
| Dorsey & Whitney Trust CO LLC | 12,265 | $38.9K |
| GTS Securities LLC | 10,994 | $34.9K |
| Van Eck Associates Corp | 2,337 | $7.00K |
| Cutler Group LP | 1,360 | $4.00K |
| NBC Securities, Inc. | 200 | $0 |
Not filed for Q4 2023 yet (2)
Institutions that held Allogene Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Virginia Retirement Systems Et Al | 127,000 | $402.6K |
| Rothschild Investment Corp | 29,850 | $95.0K |